Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Development of a sustainable antimicrobial biopolymer film for preventing post-harvest food spoilage.

International journal of biological macromolecules·2026
Same author

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same author

Academic point-of-care anti-CD19 CAR T-cell therapy induces durable remission and transient paroxysmal nocturnal hemoglobinuria-type cell expansion in a patient with multi-refractory immune thrombocytopenia.

Haematologica·2026
Same author

CD177 Deficiency Defines a Stable Subtype of Human Neutrophil Granulocytes with Tumor Promoting Activity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation.

EClinicalMedicine·2026

Related Experiment Video

Updated: Jul 7, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.2K

Mouse models of diffuse large B cell lymphoma.

Areya Tabatabai1, Aastha Arora1, Svenja Höfmann1

  • 1Department of Hematology and Stem Cell Transplantation, University Hospital Essen, West German Cancer Center, German Cancer Consortium Partner Site Essen, Center for Molecular Biotechnology, University of Duisburg-Essen, Essen, Germany.

Frontiers in Immunology
|December 21, 2023
PubMed
Summary
This summary is machine-generated.

Developing accurate mouse models is crucial for understanding Diffuse Large B cell Lymphoma (DLBCL) heterogeneity and improving treatment strategies for patients with relapsed or refractory disease.

Keywords:
animal modelsdiffuse large B cell lymphoma (DLBCL)genetically engineered (GE) animalslymphomamouse models

More Related Videos

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K

Related Experiment Videos

Last Updated: Jul 7, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.2K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K

Area of Science:

  • Oncology
  • Genetics
  • Immunology

Background:

  • Diffuse Large B cell Lymphoma (DLBCL) is a genetically diverse cancer.
  • Current treatments fail to cure 35% of patients, leading to relapsed or refractory disease.
  • Advanced treatments like CAR-T cells still face challenges in treating these patients.

Purpose of the Study:

  • To review the current state of mouse models for Diffuse Large B cell Lymphoma (DLBCL).
  • To highlight the importance of these models in capturing disease biology and heterogeneity.
  • To discuss genetically defined vulnerabilities and potential therapeutic targets.

Main Methods:

  • Discussion of existing literature on DLBCL mouse models.
  • Analysis of recent genomic characterization studies of DLBCL.
  • Focus on autochthonous, cell line-derived, and patient-derived mouse models.

Main Results:

  • Genomic studies provide a framework for creating better DLBCL mouse models.
  • Mouse models are essential for studying DLBCL biology and heterogeneity.
  • These models can inform the development of targeted therapies.

Conclusions:

  • Improved mouse models are needed to address the high unmet medical need in DLBCL.
  • Genetically defined molecular subgroups of DLBCL offer opportunities for targeted therapies.
  • Future research should focus on developing and validating sophisticated mouse models for DLBCL drug discovery.